New method for measuring HIV viral load using advanced technology.
Ultrasensitive HIV viral load quantitation using designer DNA nanostructure capture probes and photonic resonator interference scattering microscopy
['FUNDING_R01'] · STANFORD UNIVERSITY · NIH-11034119
This study is working on a new, easier way to measure the amount of HIV in the blood, which can help people with HIV get better treatment and reduce the chances of passing it to their babies, especially in places where resources are limited.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11034119 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a highly sensitive and accurate method for monitoring HIV-1 viral load, which is crucial for effective antiretroviral therapy and reducing mother-to-child transmission of HIV. The approach involves innovative techniques such as microfluidic separation of viruses from blood samples and the use of designer DNA nanostructures to selectively capture HIV virions. By simplifying the testing process and improving its reliability, this research aims to create a cost-effective solution suitable for use in resource-limited settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV who require regular viral load monitoring.
Not a fit: Patients who are not infected with HIV or those who do not require viral load testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and reliable HIV testing, improving patient management and outcomes.
How similar studies have performed: Previous research has shown promise in using innovative technologies for viral load testing, indicating potential success for this novel approach.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DEMIRCI, UTKAN — STANFORD UNIVERSITY
- Study coordinator: DEMIRCI, UTKAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus